Posted by Michael Wonder on 14 Feb 2023
Scotland becomes first part of UK to approve new cervical cancer drug
13 February 2023 - The SMC has approved the use of the drug pembrolizumab – which is also known as Keytruda – to treat those patients with persistent or recurrent cervical cancer, or in cases where the disease has spread.
Campaigners have hailed the decision as giving “new options, hope and most importantly time to those living with advanced cervical cancer”.
